{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T21:59:45Z","timestamp":1789595985277,"version":"build-2803163510"},"reference-count":41,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2023,3,6]],"date-time":"2023-03-06T00:00:00Z","timestamp":1678060800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,12,22]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>To assess clinical features in patients with polymyalgia rheumatica (PMR) in Japan by the International Classification of Disease (ICD)-10 code assignment.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Demographics, treatment patterns, and concomitant diseases (identified using ICD-10 code only) in patients who were assigned the PMR ICD-10 code M35.3 at least once between 1 January 2015 and 31 December 2020 were aggregated from a nationwide medical information database owned by the Health, Clinic, and Education Information Evaluation Institute.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>The cumulative number of patients with PMR was 6325 (mean [standard deviation] age, 74.3 [11.4] years; male:female, 1:1.3). Most patients were &amp;gt;50\u2009years (96.5%) with &amp;gt;33% between 70 and 79\u2009years. Glucocorticoids were prescribed in \u223c54% of patients within 30\u2009days of PMR code assignment. All other drug types were prescribed in &amp;lt;5% of patients. Hypertension, diabetes mellitus, rheumatoid arthritis, and osteoporosis were noted in &amp;gt;25% and giant cell arteritis in 1% of patients. During the study period, 4075 patients were newly assigned the PMR code and 62% were prescribed glucocorticoids within 30\u2009days.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>This is the first retrospective real-world data analysis describing the clinical features of PMR in a large patient population from Japan. Further studies of prevalence, incidence, and clinical features are warranted in patients with PMR.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/mr\/road026","type":"journal-article","created":{"date-parts":[[2023,3,7]],"date-time":"2023-03-07T19:19:46Z","timestamp":1678216786000},"page":"201-207","source":"Crossref","is-referenced-by-count":13,"title":["Clinical features of polymyalgia rheumatica patients in Japan: Analysis of real-world data from 2015 to 2020"],"prefix":"10.1093","volume":"34","author":[{"given":"Yoshiya","family":"Tanaka","sequence":"first","affiliation":[{"name":"The First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Japan , Kitakyushu, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichi","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Medical Affairs Department, Asahi Kasei Pharma Corporation , Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiya","family":"Takahashi","sequence":"additional","affiliation":[{"name":"Specialty Care Medical, Sanofi K.K. , Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoto","family":"Kato","sequence":"additional","affiliation":[{"name":"Medical Affairs Department, Asahi Kasei Pharma Corporation , Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,3,6]]},"reference":[{"key":"2023122314261984300_R1","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1007\/s00296-011-1849-3","article-title":"The rate of polymyalgia rheumatica (PMR) and remitting seronegative symmetrical synovitis with pitting edema (RS3PE) syndrome in a clinic where primary care physicians are working in Japan","volume":"32","author":"Okumura","year":"2012","journal-title":"Rheumatol Int"},{"key":"2023122314261984300_R2","doi-asserted-by":"crossref","first-page":"182","DOI":"10.3899\/jrheum.141179","article-title":"Development of a provisional core domain set for polymyalgia rheumatica: report from the OMERACT 12 Polymyalgia Rheumatica Working Group","volume":"43","author":"Helliwell","year":"2016","journal-title":"J Rheumatol"},{"key":"2023122314261984300_R3","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.semarthrit.2020.05.003","article-title":"Comorbidities in patients with polymyalgia rheumatica prior to and following diagnosis: a case control and cohort study","volume":"50","author":"Partington","year":"2020","journal-title":"Semin Arthritis Rheum"},{"key":"2023122314261984300_R4","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1016\/S0140-6736(17)31825-1","article-title":"Polymyalgia rheumatica","volume":"390","author":"Gonz\u00e1lez-Gay","year":"2017","journal-title":"The Lancet"},{"key":"2023122314261984300_R5","doi-asserted-by":"crossref","first-page":"297","DOI":"10.4078\/jrd.2014.21.6.297","article-title":"Epidemiology of polymyalgia rheumatica in Korea","volume":"21","author":"Kim","year":"2014","journal-title":"J Rheum Dis"},{"key":"2023122314261984300_R6","doi-asserted-by":"crossref","first-page":"e783","DOI":"10.3399\/bjgp18X699557","article-title":"Challenges of diagnosing and managing polymyalgia rheumatica: a multi-methods study in UK general practice","volume":"68","author":"Helliwell","year":"2018","journal-title":"Br J Gen Pract"},{"key":"2023122314261984300_R7","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1093\/rheumatology\/kep303a","article-title":"BSR and BHPR guidelines for the management of polymyalgia rheumatica","volume":"49","author":"Dasgupta","year":"2010","journal-title":"Rheumatology (Oxford)"},{"key":"2023122314261984300_R8","doi-asserted-by":"crossref","first-page":"452","DOI":"10.2169\/internalmedicine1962.28.452","article-title":"Clinical studies of polymyalgia rheumatica. A proposal of diagnostic criteria","volume":"28","author":"Nobunaga","year":"1989","journal-title":"Jpn J Med"},{"key":"2023122314261984300_R9","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1177\/1759720X13512450","article-title":"Advances and challenges in the diagnosis and treatment of polymyalgia rheumatica","volume":"6","author":"Kermani","year":"2014","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"2023122314261984300_R10","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.semarthrit.2020.07.005","article-title":"Incidence and prevalence of giant cell arteritis and polymyalgia rheumatica: a systematic literature review","volume":"50","author":"Sharma","year":"2020","journal-title":"Semin Arthritis Rheum"},{"key":"2023122314261984300_R11","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1001\/jama.2016.5444","article-title":"Polymyalgia rheumatica and giant cell arteritis: a systematic review","volume":"315","author":"Buttgereit","year":"2016","journal-title":"JAMA"},{"key":"2023122314261984300_R12","doi-asserted-by":"crossref","first-page":"274","DOI":"10.2177\/jsci.32.274","article-title":"Clinical features in patients with polymyalgia rheumatica (in Japanese)","volume":"32","author":"Aoki","year":"2009","journal-title":"Nihon Rinsho Meneki Gakkai Kaishi"},{"key":"2023122314261984300_R13","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/S0303-8467(01)00163-9","article-title":"Polymyalgia rheumatica (PMR): clinical, laboratory, and immunofluorescence studies in 13 patients","volume":"104","author":"Shintani","year":"2002","journal-title":"Clin Neurol Neurosurg"},{"key":"2023122314261984300_R14","doi-asserted-by":"crossref","first-page":"391","DOI":"10.2147\/CIA.S7489","article-title":"Clinical, radiological, and biochemical characteristics in patients with diseases mimicking polymyalgia rheumatica","volume":"4","author":"Yanai","year":"2009","journal-title":"Clin Interv Aging"},{"key":"2023122314261984300_R15","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1136\/annrheumdis-2015-207492","article-title":"2015 Recommendations for the management of polymyalgia rheumatica: a European League Against Rheumatism\/American College of Rheumatology collaborative initiative","volume":"74","author":"Dejaco","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"2023122314261984300_R16","doi-asserted-by":"crossref","first-page":"552","DOI":"10.3899\/jrheum.110851","article-title":"Adverse events during long-term low-dose glucocorticoid treatment of polymyalgia rheumatica: a retrospective study","volume":"39","author":"Mazzantini","year":"2012","journal-title":"J Rheumatol"},{"key":"2023122314261984300_R17","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1080\/14656566.2018.1501360","article-title":"Drug therapies for polymyalgia rheumatica: a pharmacotherapeutic update","volume":"19","author":"Gonzalez-Gay","year":"2018","journal-title":"Expert Opin Pharmacother"},{"key":"2023122314261984300_R18","doi-asserted-by":"crossref","first-page":"369","DOI":"10.3109\/s10165-007-0595-6","article-title":"Clinical characteristics of polymyalgia rheumatica in Japanese patients: evidence of synovitis and extracapsular inflammatory changes by fat suppression magnetic resonance imaging","volume":"17","author":"Mori","year":"2007","journal-title":"Mod Rheumatol"},{"key":"2023122314261984300_R19","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1620\/tjem.251.125","article-title":"High relapse rate in patients with polymyalgia rheumatica despite the combination of immunosuppressants and prednisolone: a single center experience of 89 patients","volume":"251","author":"Okazaki","year":"2020","journal-title":"Tohoku J Exp Med"},{"key":"2023122314261984300_R20","article-title":"Survey of Japanese databases in Japan available for clinical\/pharmacoepidemiology","author":"Pharmacoepidemiology & Database Taskforce JSfP"},{"key":"2023122314261984300_R21","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1002\/art.34356","article-title":"2012 Provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism\/American College of Rheumatology collaborative initiative","volume":"64","author":"Dasgupta","year":"2012","journal-title":"Arthritis Rheum"},{"key":"2023122314261984300_R22","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.3899\/jrheum.101149","article-title":"The accuracy of administrative data diagnoses of systemic autoimmune rheumatic diseases","volume":"38","author":"Bernatsky","year":"2011","journal-title":"J Rheumatol"},{"key":"2023122314261984300_R23","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-045343","article-title":"Impact of COVID-19 pandemic on utilisation of healthcare services: a systematic review","volume":"11","author":"Moynihan","year":"2021","journal-title":"BMJ Open"},{"key":"2023122314261984300_R24","doi-asserted-by":"crossref","first-page":"e173","DOI":"10.1093\/bjs\/znab028","article-title":"Impact of the early stage of the coronavirus disease 2019 pandemic on surgical volume in Japan","volume":"108","author":"Okuno","year":"2021","journal-title":"Br J Surg"},{"key":"2023122314261984300_R25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2106\/JBJS.20.00775","article-title":"Impact of COVID-19 on orthopaedic and trauma service: an epidemiological study","volume":"102","author":"Wong","year":"2020","journal-title":"J Bone Joint Surg Am"},{"key":"2023122314261984300_R26","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1093\/mr\/roab036","article-title":"Clinical analysis of gender and pre-existing diabetes mellitus in patients with polymyalgia rheumatica: a retrospective study in a Japanese population","volume":"32","author":"Horai","year":"2022","journal-title":"Mod Rheumatol"},{"key":"2023122314261984300_R27","first-page":"475","article-title":"Membars of Japan Physicians Association in Tanabe City. Seasonal onset of polymyalgia rheumatica and examination of the incidence rate (in Japanese)","volume":"26","author":"Yasuhito Yamanishi","year":"2011","journal-title":"J Jpn Soc Clin Phys"},{"key":"2023122314261984300_R28","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1093\/mr\/roac024","article-title":"Usefulness of ultrasound as a predictor of elderly-onset rheumatoid arthritis with polymyalgia rheumatica-like onset","volume":"33","author":"Nawata","year":"2023","journal-title":"Mod Rheumatol"},{"key":"2023122314261984300_R29","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1002\/acr.23132","article-title":"Epidemiology of polymyalgia rheumatica 2000-2014 and examination of incidence and survival trends over 45 years: a population-based study","volume":"69","author":"Raheel","year":"2017","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2023122314261984300_R30","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1136\/annrheumdis-2018-213883","article-title":"Incidence, prevalence and treatment burden of polymyalgia rheumatica in the UK over two decades: a population-based study","volume":"77","author":"Partington","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"2023122314261984300_R31","first-page":"1694","article-title":"Trends in the incidence of polymyalgia rheumatica over a 30 year period in Olmsted County, Minnesota, USA","volume":"29","author":"Doran","year":"2002","journal-title":"J Rheumatol"},{"key":"2023122314261984300_R32","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1111\/jdi.12333","article-title":"Impact of population aging on trends in diabetes prevalence: a meta-regression analysis of 160,000 Japanese adults","volume":"6","author":"Charvat","year":"2015","journal-title":"J Diabetes Investig"},{"key":"2023122314261984300_R33","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1007\/s00774-009-0080-8","article-title":"Prevalence of knee osteoarthritis, lumbar spondylosis, and osteoporosis in Japanese men and women: the research on osteoarthritis\/osteoporosis against disability study","volume":"27","author":"Yoshimura","year":"2009","journal-title":"J Bone Miner Metab"},{"key":"2023122314261984300_R34","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1002\/art.11195","article-title":"Clinical and epidemiologic analysis of giant cell (temporal) arteritis from a nationwide survey in 1998 in Japan: the first government-supported nationwide survey","volume":"49","author":"Kobayashi","year":"2003","journal-title":"Arthritis Rheum"},{"key":"2023122314261984300_R35","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/s41584-021-00718-8","article-title":"Global epidemiology of vasculitis","volume":"18","author":"Watts","year":"2022","journal-title":"Nat Rev Rheumatol"},{"key":"2023122314261984300_R36","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1161\/CIRCRESAHA.118.313206","article-title":"MMP (matrix metalloprotease)-9-producing monocytes enable T cells to invade the vessel wall and cause vasculitis","volume":"123","author":"Watanabe","year":"2018","journal-title":"Circ Res"},{"key":"2023122314261984300_R37","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.semarthrit.2015.01.005","article-title":"Extra-cranial giant cell arteritis and Takayasu arteritis: how similar are they?","volume":"44","author":"Kermani","year":"2015","journal-title":"Semin Arthritis Rheum"},{"key":"2023122314261984300_R38","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1002\/acr.24403","article-title":"Mortality among patients with polymyalgia rheumatica: a retrospective cohort study","volume":"73","author":"Partington","year":"2021","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2023122314261984300_R39","doi-asserted-by":"crossref","first-page":"i14","DOI":"10.1093\/rheumatology\/keu210.007","article-title":"Gender differences in health-related quality of life in polymyalgia rheumatica","volume":"53","author":"Hollywood","year":"2014","journal-title":"Rheumatology"},{"key":"2023122314261984300_R40","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1002\/art.22777","article-title":"Clinical outcomes, quality of life, and diagnostic uncertainty in the first year of polymyalgia rheumatica","volume":"57","author":"Hutchings","year":"2007","journal-title":"Arthritis Rheum"},{"key":"2023122314261984300_R41","article-title":"News Bulletin No. 326.","author":"Statistics Bureau of Japan"}],"container-title":["Modern Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/mr\/advance-article-pdf\/doi\/10.1093\/mr\/road026\/49688509\/road026.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/mr\/article-pdf\/34\/1\/201\/54800131\/road026.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/mr\/article-pdf\/34\/1\/201\/54800131\/road026.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,23]],"date-time":"2023-12-23T14:27:46Z","timestamp":1703341666000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/mr\/article\/34\/1\/201\/7070611"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,6]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,3,6]]},"published-print":{"date-parts":[[2023,12,22]]}},"URL":"https:\/\/doi.org\/10.1093\/mr\/road026","relation":{},"ISSN":["1439-7595","1439-7609"],"issn-type":[{"value":"1439-7595","type":"print"},{"value":"1439-7609","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,1,1]]},"published":{"date-parts":[[2023,3,6]]}}}